Prof. Dr. İLHAMİ BERBER | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

Makaleler 117

1. A RARE DIAGNOSIS IN ADULTS: HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA

ARSLAN S., BERBER İ., KUKU İ., KAYA E., ERKURT M. A., SARICI A., et al.

Hematology, Transfusion and Cell Therapy , cilt.47, ss.9-1, 2025 (ESCI, Scopus)

2. Ameliorative effects of humic acid on copper-induced liver injury via antioxidant and chelating mechanisms

ÇAĞIN Y. F., ATAYAN Y., ÖZHAN O., BERBER İ., YILDIZ A., DOĞRU F., et al.

Medicine Science , cilt.14, sa.4, ss.1272-1279, 2025 (TRDizin)

3. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Karakus A., Hatipoglu U., Katircilar Y., ERKURT M. A., Yilmaz S., Cagliyan G. A., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

4. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., Yilmaz S., Demircioglu S., BERBER İ., Basturk A., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

5. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?

ERKURT M. A., Yilmaz S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

6. The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation

BATGİ H., Zorlu T., ERKURT M. A., UZAY A., Hindilerden I. Y., Pepeler M. S., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

7. Disruption of kinesthesia and position sense in the ankle joint is an independent predictor of falls in elderly patients undergoing hemodialysis

Ulutas N. S., Bentli R., BERBER I., Ulutaş Ö.

Annals of Medical Research , cilt.32, sa.3, ss.126-130, 2025 (TRDizin)

8. Effectiveness of ibrutinib in the management of chronic GVHD

ERKURT M. A., SARICI A., Sahin A., BERBER İ., Korkmaz G., KUKU İ., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

9. Efficacy of Ruxolitinib in the management of chronic GVHD

Giden A. O., ERKURT M. A., Hindilerden I. Y., Hidayet E., BERBER İ., Tiryaki T. O., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

10. The role of ruxolitinib in the management of acute GVHD

NAMDAROĞLU S., Hidayet E., Aydin M. S., ERKURT M. A., BERBER İ., Cinar O. E., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

11. What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Ulas T., NAMDAROĞLU S., Hindilerden I. Y., ERKURT M. A., Erer K., Yigenoglu T. N., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

12. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

Bakirtas M., Hindilerden I. Y., Ulu B. U., Ekinci O., Dogu M. H., Aydogdu I., et al.

Indian Journal of Hematology and Blood Transfusion , 2025 (SCI-Expanded, Scopus)

13. Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

ACTA HAEMATOLOGICA POLONICA , cilt.55, 2024 (Scopus)

14. Effects of extracorporeal photopheresis on survival in chronic graft versus host disease

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.

MARMARA MEDICAL JOURNAL , cilt.37, 2024 (ESCI, Scopus, TRDizin)

15. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

Çelik S., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.

Journal of Current Hematology &amp; Oncology Research , cilt.2, 2024 (TRDizin)

16. Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?

KAYA A., BERBER İ., KAYA E., ERKURT M. A., BİÇİM S., ARSLAN S., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI, Scopus)

17. Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center

ERYILDIZ S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ.

Journal of Current Hematology &amp; Oncology Research , cilt.2, 2024 (TRDizin)

18. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients

BİÇİM S., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KAYA A., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI, Scopus)

Creative Commons License

19. How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-center Experience

Uysal A., ERKURT M. A., KUKU I., Kaya E., BERBER I., SARICI A., et al.

ACTA ONCOLOGICA TURCICA , cilt.56, sa.2, ss.106-113, 2023 (TRDizin)

Creative Commons License

20. The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.

İstanbul Medical Journal , cilt.24, sa.2, ss.216-220, 2023 (TRDizin)

21. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

SERİN İ., DOĞU M., EKINCI O., ÇAĞLIYAN G. A., BAŞTÜRK A., ARAS M. R., et al.

İstanbul Medical Journal , cilt.24, sa.2, ss.120-125, 2023 (TRDizin)

22. The effect of CD 34+ stem cell dose on both short-term and long-term outcomes of autologous stem cell transplantation in multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

Annals of Medical Research , cilt.30, sa.3, ss.331-336, 2023 (TRDizin)

23. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Thalassemia: A Single-Center Experience and Literature Review

UYSAL A., ERKURT M. A., SARICI A., KUKU İ., BİÇİM S., HİDAYET E., et al.

Fırat Tıp Dergisi , cilt.28, sa.1, ss.46-50, 2023 (TRDizin)

24. A case of malignant melanoma presented with lombar vertebra fracture

SARICI A., KUKU İ., BERBER İ., ERKURT M. A., ER ULUBABA H., BİÇİM S., et al.

Journal of Current Hematology & Oncology Research , cilt.1, 2023 (TRDizin)

Creative Commons License

25. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

KAYA A., BERBER İ., KUKU İ., ÇELİK S., KAYA E., BİÇİM S., et al.

Journal of Current Hematology & Oncology Research , cilt.1, 2023 (TRDizin)

Creative Commons License

26. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

MARMARA MEDICAL JOURNAL , cilt.36, 2023 (ESCI, Scopus, TRDizin)

Creative Commons License

27. The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers.

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.61, sa.6, ss.103482, 2022 (SCI-Expanded, Scopus)

28. The frequency of HLA A, B, C, DP, DQ, DR allele in patients of Turkish and Syrian nationals with allogeneic stem cell transplantation

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.11, sa.2, ss.110-117, 2022 (Hakemli Dergi)

29. Identification of lymphocyte subgroups with flow cytometry in COVID-19 patients

BERBER İ., KIRICI BERBER N., SARICI A., GÖZÜKARA BAĞ H. G., BİÇİM S., TURGUT B., et al.

JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.5, sa.4, ss.1183-1189, 2022 (TRDizin)

30. Effects Of Ethnicity On Allogenic Stem Cell Mobilization

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

International Journal of Clinical Images and Medical Reviews , cilt.2, sa.2, ss.1-4, 2022 (Hakemli Dergi)

31. Convalescent plasma therapy in COVID-19

UYSAL A., ERKURT M. A., KUKU İ., SARICI A., BİÇİM S., KAYA E., et al.

Medicine Science , cilt.11, sa.2, ss.920-923, 2022 (TRDizin)

32. The effect of comorbidity on survival and collected CD34+cell counts in autologous hematopoietic stem cell transplant patients

SARICI A., ERKURT M. A., KUKU İ., Bahcecioglu O. F., Bicim S., KAYA E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.61, sa.1, 2022 (SCI-Expanded, Scopus)

33. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.

INTERNAL AND EMERGENCY MEDICINE , cilt.17, sa.1, ss.135-139, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

34. Non-infectious Complications in Patients with Allogeneic Hematopoietic Stem Cell Transplantation- Single Center Experience from Eastern Anatolia

KARAMAN S., SARICI A., ERKURT M. A., BİÇİM S., HİDAYET E., KAYA A., et al.

ACTA ONCOLOGICA TURCICA , cilt.55, 2022 (TRDizin)

35. The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma

BİÇİM S., BERBER İ., ERKURT M. A., KUKU İ., KAYA E., BİLGİÇ Y., et al.

International Journal of Research and Reports in Hematology , cilt.5, sa.2, ss.1-5, 2022 (Hakemli Dergi)

36. The effect of cryopreserved and noncryopreserved stem cells on the outcome of autologous stem-cell transplantation in multiple myeloma patients: A single-center experience

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

EGYPTIAN JOURNAL OF HAEMATOLOGY , cilt.47, 2022 (Hakemli Dergi)

37. Predictive Significance of Mean Platelet Volume and Platelet Distribution Width Level in Immune Thrombocytopenia Patients Treated With Steroids

KAYA A., KUKU İ., ERKURT M. A., KAYA E., BERBER İ., SARICI A., et al.

International Journal of Research and Reports in Hematology , cilt.5, sa.1, ss.27-33, 2022 (Hakemli Dergi)

38. Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia

HİDAYET E., ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., et al.

Medicine Science , cilt.11, 2022 (TRDizin)

39. Life saving effect of early use of convalescent plasma in Covid-19 treatment

SARICI A., ERKURT M. A., KUKU İ., BİÇİM S., BERBER İ., KAYA E., et al.

Annals of Medical Research , cilt.28, sa.12, ss.2242-2247, 2021 (TRDizin)

40. Pas III Added Donor Platelet Suspensions on Platelet Count Ph and Allergic Transfusion Reactions

Özgül M., KUKU İ., ERKURT M. A., SARICI A., BİÇİM S., BERBER İ., et al.

International Journal of Research and Reports in Hematology , cilt.4, sa.2, 2021 (Hakemli Dergi)

41. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Sarıcı A., Erkurt M. A., Bahçecioğlu Ö. F., Tanriverdi L. H., Berber İ., Kaya E., et al.

Annals of Medical Research , cilt.28, sa.11, ss.2065-2070, 2021 (TRDizin)

42. Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis

BERBER İ., Cagin Y. F., ERDOĞAN M. A., Ataman E., GÖZÜKARA BAĞ H. G., ERKURT M. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

43. The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients

ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

44. Therapeutic plasma exchange for envenomation: Is it reasonable?

BERBER İ., Korkmaz S., SARICI A., ERKURT M. A., KUKU İ., KAYA E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

45. An innovation in stem cell harvesting: Heparin use

GÜL H. G., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

46. Apheresis in patients with sepsis: A multicenter retrospective study

Aydin K., Korkmaz S., ERKURT M. A., SARICI A., Ekinci O., Baysal N. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

47. Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study

SARICI A., ERKURT M. A., KUKU İ., Gok S., Bahcecioglu O. F., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

48. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura

Basturk A., Sayin S., ERKURT M. A., SARICI A., Ekinci O., Kum A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

49. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience

Batgi H., Dal M. S., ERKURT M. A., KUKU İ., Kurtoglu E., Hindilerden I. Y., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

50. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study

Dal Sinan M., Batgi H., ERKURT M. A., Hindilerden I. Y., KUKU İ., Kurtoglu E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

51. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients

SARICI A., ERKURT M. A., Bahcecioglu O. F., Gok S., KUKU İ., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded, Scopus)

52. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma-Single center experience

SARICI A., ERKURT M. A., Bahcecioglu O. F., Bicim S., BERBER İ., Gok S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded, Scopus)

53. FLAMSA vs BU-FLU in patients undergoing allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome

SARICI A., ERKURT M. A., KUKU İ., Gök S., Bahçecioğlu Ö. F., BİÇİM S., et al.

Medical Science and Discovery , cilt.8, sa.6, ss.356-360, 2021 (Hakemli Dergi)

54. Experience of ibrutinib in a patient with recurrent mantle cell lymphoma with orbital involvement

SARICI A., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BİÇİM S., et al.

Medicine Science , cilt.10, sa.4, ss.1542-1545, 2021 (TRDizin)

55. Comparison of efficacy and toxicity of treosulfan-fludarabine and busulfan-cyclophosphamide conditioning regimens in patients undergoing allogeneic stem cell transplantation

SARICI A., ERKURT M. A., KUKU İ., BAHÇECİOĞLU Ö. F., GÖK S., BİÇİM S., et al.

Medicine Science , cilt.10, sa.4, ss.1133-1137, 2021 (TRDizin)

56. COVID-19 in hematopoietic cell transplant recipients

Altuntas F., Ata N., Yigenoglu T. N., Basci S., Dal M. S., Korkmaz S., et al.

BONE MARROW TRANSPLANTATION , cilt.56, sa.4, ss.952-955, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

57. The outcome of COVID-19 in patients with hematological malignancy

Yigenoglu T. N., Ata N., Altuntas F., Basci S., Dal M. S., Korkmaz S., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.93, sa.2, ss.1099-1104, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

58. BK virus incidence, risk factors and its effect on mortality in hematopoietic stem cell transplant patients-single center experience

DEVİREN M. V., SARICI A., ERKURT M. A., BAHÇECİOĞLU Ö. F., BİÇİM S., BERBER İ., et al.

Medicine Science , cilt.10, sa.3, ss.856-859, 2021 (TRDizin)

59. COVID-19 clinical course and blood groups: Turkish population-based study

DAL M. S., Ata N., Altuntas F., Basci S., Yigenoglu T. N., Korkmaz S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1659-1664, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

60. Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., et al.

Annals of Medical Research , cilt.28, sa.12, ss.2239-2241, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

61. The impact of laboratory features and comorbidities on the prognosis of patients with Covid-19

SARICI A., KIRICI BERBER N., Cağasar Ö., BİÇİM S., Yasir F. Ç., ULUTAŞ Ö., et al.

Journal of Health Sciences and Medicine , cilt.4, sa.2, ss.142-146, 2021 (TRDizin) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

62. Peripheral Blood Smear Findings of COVID-19 Patients Provide Information about the Severity of the Disease and the Duration of Hospital Stay

BERBER İ., Cagasar O., SARICI A., Berber N. K., AYDOĞDU İ., ULUTAŞ Ö., et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.13, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

63. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

TOMBAK A., Tanrikulu F. P., Durusoy S. S., DİNÇYÜREK H. D., KAYA E., ÜMİT E. G., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.4, ss.273-285, 2021 (SCI-Expanded, Scopus, TRDizin)

64. Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

SARICI A., KAYA E., ERKURT M. A., BERBER İ., TANRİVERDİ L. H., bahçecioğlu ö. f., et al.

Annals of Medical Research , cilt.28, sa.10, ss.1824-1829, 2021 (TRDizin)

65. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia

ERKURT M. A., SARICI A., BERBER İ., KUKU İ., KAYA E., Ozgul M.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.5, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

66. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.7, ss.1676-1682, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

67. Convalescent plasma therapy in patients withCOVID-19

Yigenoglu T. N., HACIBEKİROĞLU T., BERBER İ., Dal M. S., BAŞTÜRK A., Namdaroglu S., et al.

JOURNAL OF CLINICAL APHERESIS , cilt.35, sa.4, ss.367-373, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

68. Clinical Features and Laboratory Values Associated with Disease Severity in Covid 19 Patients: A Single Center Experience

KIRICI BERBER N., ULUTAŞ Ö., SARICI A., Yıldırım A., Çağaşar Ö., GÖZÜKARA BAĞ H. G., et al.

Journal of Health Sciences and Medicine , sa.1, ss.18-22, 2020 (TRDizin) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

69. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

Okay M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)

70. Drug-drug interactions in intensive care units and potential clinical consequences of these interactions

OKSUZ E., BUĞDAY M. S., SOYALP C., KARAASLAN E., OTO G., TEMELLİ GOCEROGLU R., et al.

Annals of Medical Research , cilt.26, sa.10, ss.2158-2163, 2019 (TRDizin)

71. The Turkish experience with therapeutic plasma exchange: A national survey

Korkmaz S., Medeni S. S., DEMİRKAN F., Besisik S. K., Dadin S. A., ÇAĞLIYAN G. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.3, ss.287-292, 2019 (SCI-Expanded, Scopus)

72. The risk factors of portal vein thrombosis in patients with liver cirrhosis

Cagin Y. F., BİLGİÇ Y., Berber İ., YILDIRIM O., ERDOĞAN M. A., Firat F., et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE , cilt.17, sa.4, ss.3189-3194, 2019 (SCI-Expanded)

73. Enzyme Replacement Therapy in a Gaucher Family

Erdem N., Buran T., BERBER İ., Aydogdu I.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.110, sa.4, ss.330-333, 2018 (SCI-Expanded, Scopus)

74. EFFECTS OF RENAL REPLACEMENT THERAPY ON FIBROMYALGIA SYNDROME IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Berber İ., ŞAHİN İ., Gorgel A., Cagin Y. F., GÖZÜKARA BAĞ H. G., Berber N. K.

ACTA MEDICA MEDITERRANEA , cilt.34, sa.2, ss.337-343, 2018 (SCI-Expanded, Scopus)

75. Eosinophilic ascites, as a rare manifestation of eosinophilic gastroenteritis: a case report

ÇAĞIN Y. F., BİLGİÇ Y., BERBER İ., ERDOĞAN M. A., YILDIRIM O., Altunel Kilinc E., et al.

Annals of Medical Research , cilt.25, sa.2, ss.284-287, 2018 (TRDizin)

76. The effects of home oxygen therapy on energy metabolism in patients with COPD

Berber N. K., YETKİN Ö., Kilic T., Berber İ., Ozgel M.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE , cilt.13, ss.1577-1582, 2018 (SCI-Expanded, Scopus)

77. Assessing Safety of Pneumatic Tube System (PTS) for Patients with Very Low Hematologic Parameters

Koroglu M., ERKURT M. A., KUKU İ., KAYA E., Berber İ., Nizam I., et al.

MEDICAL SCIENCE MONITOR , cilt.22, ss.1329-1333, 2016 (SCI-Expanded, Scopus)

78. DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience

BERBER İ., ERKURT M. A., KUKU İ., Maya E., Bag H. G., NIZAM I., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.48-52, 2016 (SCI-Expanded, Scopus)

79. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation?

Dogu M. H., KAYA E., Berber İ., SARI İ., Tekgunduz E., ERKURT M. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.76-79, 2016 (SCI-Expanded, Scopus)

80. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study

ERKURT M. A., Berber İ., Tekgunduz E., Dogu M. H., Korkmaz S., Demir C., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.80-84, 2016 (SCI-Expanded, Scopus)

81. Leukapheresis Treatment in Elderly Acute Leukemia Patients with Hyperleukocytosis: A Single Center Experience

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., Bag H. G., NIZAM I., et al.

JOURNAL OF CLINICAL APHERESIS , cilt.31, sa.1, ss.53-58, 2016 (SCI-Expanded, Scopus)

82. The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study

TOMBAK A., Ucar M. A., AKDENİZ A., TİFTİK E. N., ŞAHİN F., AKAY O. M., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.273-280, 2016 (SCI-Expanded, Scopus, TRDizin)

83. A hundred years after the first article, a recollection: Cabot ring

Erdem N., Berber İ., AYDOĞDU İ., Sevinc A.

KOREAN JOURNAL OF INTERNAL MEDICINE , cilt.31, sa.1, ss.199, 2016 (SCI-Expanded)

84. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience

BERBER İ., KUKU İ., ERKURT M. A., KAYA E., Bag H. G., NIZAM I., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.53, sa.2, ss.185-190, 2015 (SCI-Expanded, Scopus)

85. Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Korkmaz S., Dal M. S., Berber İ., Sahin D. G., Dogu M. H., Ayyildiz O., et al.

GERIATRICS & GERONTOLOGY INTERNATIONAL , cilt.15, sa.6, ss.729-735, 2015 (SCI-Expanded, SSCI, Scopus)

86. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange

ERKURT M. A., Berber İ., Berktas H. B., KUKU İ., KAYA E., Koroglu M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.52, sa.2, ss.194-198, 2015 (SCI-Expanded, Scopus)

87. Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience

BERBER İ., ERKURT M. A., NIZAM I., KOROGLU M., KAYA E., KUKU İ., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.9, ss.16308-16314, 2015 (SCI-Expanded)

88. CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC FACTORS AFFECTING PATIENT SURVIVAL OF PATIENTS AT 65 YEARS OF AGE OR OLDER WITH HODGKIN LYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TURKEY

Berber İ., ERKURT M. A., KEKLİK M., Dogu M. H., TERZİ H., Pala C., et al.

ACTA MEDICA MEDITERRANEA , cilt.31, sa.6, ss.1195-1202, 2015 (SCI-Expanded, Scopus)

89. Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report

Berber İ., ERKURT M. A., KUKU İ., KAYA E., Unlu S., ERTEM K., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.51, sa.1, ss.73-76, 2014 (SCI-Expanded, Scopus)

90. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation

BERBER İ., ERKURT M. A., KUKU İ., KAYA E.

American Journal of Medical Sciences And Medicine , 2014 (Hakemli Dergi)

91. As a Rare Disease Bernard Soulier Syndrome in Differential Diagnosis of Immune Thrombocytopenic Purpura A Case Report

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.5, ss.102-106, 2014 (Hakemli Dergi)

92. Atypical Presentation of Plasmacytoma

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.4, ss.82-83, 2014 (Hakemli Dergi)

93. Acute Myeloid Leukemia Significance of the Skin Test

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.3, ss.55-56, 2014 (Hakemli Dergi)

94. Etiologic Factors of Nonalcoholic Hepatosteathosis in Malatya

GÜNDÜZ E., BENTLİ R., ULUTAŞ Ö., BERBER İ., ERKURT M. A.

Journal of Turgut Ozal MEdicine Center , cilt.21, sa.2, ss.130-134, 2014 (Hakemli Dergi)

95. Aggressive Progression of Mantle Cell Lymphoma ACase Report

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.

American Journal of Medical Case Reports , cilt.2, sa.1, ss.30-31, 2014 (Hakemli Dergi)

96. A Rare Disease in the Differential Diagnosis of Acute Pancreatitis: Acute Brucellosis

Berber İ., ERKURT M. A., YETKİN F., Unlu S., Yilmaz S., BENTLİ R., et al.

INTERNAL MEDICINE , cilt.53, sa.20, ss.2401-2404, 2014 (SCI-Expanded, Scopus)

97. An Unexpected Complication of Bone Marrow Aspiration and Trephine Biopsy: Arteriovenous Fistula

Berber İ., ERKURT M. A., KUKU İ., KAYA E., KUTLU R., Koroglu M., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.23, sa.4, ss.380-383, 2014 (SCI-Expanded, Scopus)

98. Donor Selection in Allogeneic Stem Cell Transplantation

ERKURT M. A., BERBER İ., KUKU İ., KAYA E., NİZAM İ.

American Journal of Clinical Medicine Research , cilt.2, sa.1, ss.32-35, 2014 (Hakemli Dergi)

99. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation Review Article

BERBER İ., ERKURT M. A., YETKİN F., KUKU İ., KAYA E., bodakcı e., et al.

American Journal of Medical Sciences and Medicine , cilt.2, sa.5, ss.85-88, 2014 (Hakemli Dergi)

100. Haploidentical Transplantation Experience in Turgut Ozal MedicalCenter Case Report and a Review of Literature

BERBER İ., ERKURT M. A., KAYA E., KÖROĞLU M., NİZAM İ., BENTLİ R., et al.

Journal of Turgut Ozal Medicine , cilt.21, sa.1, ss.55-58, 2014 (Hakemli Dergi)

101. Hermansky-Pudlak Syndrome: A Case Report

BERBER İ., ERKURT M. A., KUKU I., Kaya E., KOROGLU M., NIZAM I., et al.

CASE REPORTS IN HEMATOLOGY , cilt.2014, 2014 (ESCI)

102. Decitabine Induced Localized Maculopapular Eruption

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., NİZAM İ., KAYA E., et al.

British Journal of Medicine and Medical Research , cilt.4, sa.4, ss.1002-1007, 2014 (Hakemli Dergi)

103. Clinicopathological Characteristics of Pernicious Anemia A Study of 300 Patients in Turkey

BENTLİ R., BERBER İ., ERKURT M. A., AYDOĞDU İ., GÜNDÜZ E., NİZAM İ., et al.

British Journal of Medicine and Medical Research , cilt.4, sa.3, 2013 (Hakemli Dergi)

104. Roles of CD5 CD19 CD41a CD55 and CD59 in Chronic Immune Thrombocytopenic Purpura ITP

kaya f., BERBER İ., ERKURT M. A., AYDOĞDU İ., REİSLİ İ.

British Journal of Medicine and Medical Research , cilt.4, sa.2, 2013 (Hakemli Dergi)

105. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: A case report

Koroglu M., ERKURT M. A., Berber İ., KUKU İ., KAYA E., Ozkahraman A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.2, ss.341-344, 2013 (SCI-Expanded, Scopus)

106. Evans Seyndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.289-290, 2013 (Hakemli Dergi)

107. Extranasal NK Cell Lymphoma with Extensive Skin Involvement A Case Report

ERKURT M. A., BERBER İ., KARADAĞ N., BENTLİ R., KAYA E., KÖROĞLU M., et al.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.276-278, 2013 (Hakemli Dergi)

108. Familial Chronic Lymphocytic Leukemia Patients in Eastern Anatolia Region

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.287-288, 2013 (Hakemli Dergi)

109. Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia

ERKURT M. A., Kuku L., KAYA E., Ozgen U., Berber İ., Koroglu M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.335-339, 2013 (SCI-Expanded, Scopus)

110. Pulmonary Embolism as the Initial Presentation of Testicular Carcinoma

BERBER İ., BENTLİ R., ERKURT M. A., ULUTAŞ Ö., EDİZ C., NİZAM İ., et al.

CASE REPORTS IN ONCOLOGICAL MEDICINE , cilt.2013, 2013 (ESCI) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

111. A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

American Journal of Medical Case Reports , 2013 (Hakemli Dergi)

112. Double Hit Lymphoma Presenting with Aggressive Progression A CaseReport

KAYA E., ERKURT M. A., BERBER İ., KÖROĞLU M., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.1, ss.74-76, 2013 (Hakemli Dergi)

113. Burkitt s lymphoma presenting with rapidly and multi organ involvement A case presentation

BERBER İ., ERKURT M. A., KÖROĞLU M., KUKU İ., KAYA E., BENTLİ R.

Case Reports in Clinical Medicine , cilt.2, sa.04, ss.242-245, 2013 (Hakemli Dergi)

114. Doğu Anadolu Bölgesindeki Ailesel Kronik Lenfositik Lösemili Hastalarımız

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.287-288, 2013 (TRDizin)

115. Evans Syndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.289-290, 2013 (TRDizin)

116. Hypernatremia in the Emergency Department

YÜCEL N., ŞAHİN İ., AKGÜN F. S., KÖZ S., BERBER İ., Özdemir M. G.

TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.21, sa.02, ss.124-129, 2012 (ESCI, TRDizin)

117. Hipertansiyonu Renal İnfarktı ve MorgagniHernisi Olan Marfan Sendromlu Bir Olgu

karahan d., ŞAHİN İ., toylak e., BERBER İ., TAŞKAPAN H.

Journal of Turgut Ozal Medical Center , cilt.16, sa.4, ss.257-259, 2009 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 51

1. TCL-367: A Case of T-PLL Refractory to Multiple Treatments

Arslan S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BOZDAĞ Z., et al.

Society of Hematologic Oncology Thirteenth Annual Meeting, Houston, Amerika Birleşik Devletleri, 3 - 06 Eylül 2025, cilt.25, (Özet Bildiri)

2. REFRAKTER KRONİK İTP’ DE DANAZOL TEDAVİSİ

ARSLAN S., KAYA E., KUKU İ., ERKURT M. A., BERBER İ., KAYA A.

50. Ulusal Hematoloji Kongresi - 2024, 29 Ekim - 02 Kasım 2024, (Özet Bildiri)

3. SIÇANLARDA DENEYSEL OLARAK KARACİĞERDE BİRİKEN BAKIR ÜZERİNE HUMİK ASİTİN ETKİSİNİN ARAŞTIRILMASI

KİREÇ Y., ÇAĞIN Y. F., ÖZHAN O., YILDIZ A., DOĞRU F., BERBER İ.

2. Uluslararası ve 27. Ulusal Farmakoloji Kongresi, Antalya, Türkiye, 23 Kasım 2023, (Özet Bildiri)

4. İntensif Tedavi Verilemeyen Akut Myeloid Lösemi Hastalarında Venetoklaks Tedavisi Sonuçları: Tek Merkez Deneyim

BİÇİM S., KAYA E., KUKU İ., ERKURT M. A., BERBER İ., KAYA A., et al.

48. Ulusal Hematoloji Kongresi, 1 - 05 Kasım 2022, (Tam Metin Bildiri)

5. A Case Report of Liver Involvement in Multiple Myeloma

BİÇİM S., BERBER İ., KUKU İ., KAYA E., ERKURT M. A., KAYA A., et al.

WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, 14 - 17 Eylül 2022, (Tam Metin Bildiri)

6. İnönü University Turgut Özal Medical Center Red Crescent Pool Platelet Experience

HİDAYET E., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, İstanbul, Türkiye, 14 - 17 Eylül 2022, (Tam Metin Bildiri)

7. Otolog Kök Hücre Nakli Öncesi Ferritin Düzeyi Nakil Sonuçlarında Etkili Mi? Tek Merkez Deneyimi

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

5. Hematolojik Nadir Hastalıklar Kongresi, Kıbrıs (Kktc), 24 - 27 Mart 2022, (Özet Bildiri)

8. MİYELOFİBROZİSE SEKONDER MULTİPLE MİYELOM: NADİR GÖRÜLEN BİR OLGU SUNUMU

BİÇİM S., SARICI A., ŞAHİN A. Ş., BERBER İ., KUKU İ., KAYA E., et al.

4. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, DİJİTAL KONGRE, Türkiye, 30 Eylül - 03 Ekim 2021, ss.41-44, (Özet Bildiri)

9. OTOLOG HEMATOPOETİK KÖK HÜCRE NAKLİ YAPILAN MİKOZİS FUNGOİDES VAKASI

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Türkiye, 25 - 27 Aralık 2020, ss.153, (Özet Bildiri)

10. MULTİPL MYELOM HASTASINDA GÖRÜLEN COVİD-19 HASTALIĞI

SARICI A., BİLGİÇ Y., AKBAŞ S., BİÇİM S., BERBER İ., ERKURT M. A., et al.

3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Türkiye, 25 - 27 Aralık 2020, ss.148-149, (Özet Bildiri)

11. AKUT LENFOBLASTİK LÖSEMİLİ HASTADA GÖRÜLEN CİLT TUTULUMU

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Türkiye, 25 - 27 Aralık 2020, ss.150, (Özet Bildiri)

12. Covid-19 Hastalarında Hastalık Şiddetiyle İlişkili Klinik Özellikler ve Laboratuvar Değerleri : Tek Merkez Deneyimi

YILDIRIM A., KIRICI BERBER N., ULUTAŞ Ö., SARICI A., ÇAĞAŞAR Ö., GÖZÜKARA BAĞ H. G., et al.

II. Hematoloji Eğitim ve Araştırma Kongresi, Türkiye, 20 - 22 Kasım 2020, (Özet Bildiri)

13. Covid-19 Hastalarının Basit Periferik Yayma Bulgularının, Hastalığın Ciddiyeti ve Hastanede Kalış Süresi Üzerindeki Yararları

KIRICI BERBER N., BERBER İ., ÇAĞAŞAR Ö., SARICI A., AYDOĞDU İ., ULUTAŞ Ö., et al.

II. Hematoloji Eğitim ve Araştırma Kongresi, Türkiye, 20 - 22 Kasım 2020, (Özet Bildiri)

14. TANI ANINDA BÖBREK YETMEZLİĞİ OLAN MULTİPL MYELOM HASTALARININ TEDAVİ SONRASI BÖBREK FONKSİYONLARININ DEĞİŞİMİ

SARICI A., KAYA E., ERKURT M. A., TANRIVERDİ L. H., BERBER İ., BAHÇECİOĞLU Ö. F., et al.

45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, ss.219, (Özet Bildiri)

15. Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Tombak A., Tanrikulu F. P., Durusoy S. S., GÜRKAN E., KAYA E., ÜMİT E. G., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

16. Deri Tutulumu İle Prezente Extranodal NHL Olgu Sunumu

KUM A., ERKURT M. A., NİZAM İ., BERBER İ., KAYA E., KUKU İ., et al.

10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

17. Kadın Hastada Hemofili A

ÖZEN NİZAM İ., ERKURT M. A., KAYA E., BERBER İ., DOLAŞIK İ., CÖMERT ÖZKAN M., et al.

10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

18. YILAN ZEHİRLENMESİNDE ETKİLİ VE GÜVENLİ BİR TEDAVİ YÖNTEMİ PLAZMA DEĞİŞİMİ

NİZAM ÖZEN İ., ERKURT M. A., BERBER İ., KUKU İ., KAYA E., CÖMERT ÖZKAN M., et al.

10.ULUSAL AFEREZ KONGRESİ, İstanbul, Türkiye, 5 - 08 Kasım 2015

19. ALLOJENİK VE OTOLOG KÖK HÜCRE NAKLİNDE BK VİRÜS TURGUT ÖZAL TIP MERKEZİ TEK MERKEZ DENEYİMİ

ERKURT M. A., BERBER İ., NİZAM İ., SELÇUK E. B., SERAP B., KAYA E., et al.

2.HEMATOLOJİK ONKOLOJİ VE KEMİK İLİĞİ TRANSPLANTASYON SEMPOZYUMU, Türkiye, 5 - 08 Şubat 2015

20. UYGUN DONÖRLERDE ÜÇLÜ DOZ TROMBOSİT AFEREZİ DOĞU ANADOLU DAN TEK MERKEZ DENEYİMİ

ÖZGÜL M., ÖZEN İ. N., ERKURT M. A., KUKU İ., BERBER İ., DOLAŞIK İ., et al.

10.AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

21. Bu Cy E Conditioning Regimen Can Be An Alternative Treatment to BEAM at Autologous Transplantation for Lymphoma

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KUKU İ.

IX. Ulusal Aferez Kongresi, Türkiye, 4 - 07 Eylül 2014

22. Leukapheresis in elderly patients are safe and effective treatment

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., NİZAM İ., GÖZÜKARA BAĞ H. G., et al.

IX. Ulusal Aferez Kongresi, Kıbrıs (Kktc), 4 - 07 Eylül 2014, ss.177-178, (Özet Bildiri)

23. Carcinoma Causing Thrombotic Thrombocytopenic Purpura andMyelonecrosis A Very Rare Event

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ.

9. ULUSAL AFEREZ KONGRESİ, Türkiye, 4 - 07 Eylül 2014

24. UYgun Donörlerde ÜÇlü Doz Trombosit Aferezi Doğu Anadolu dan Tek Merkez Deneyimi

ÖZGÜL M., NİZAM İ., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., et al.

9. ULUSAL AFEREZ KONGRESİ, Türkiye, 4 - 07 Eylül 2014

25. The clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study.

Korkmaz S., Dal M. S., Berber İ., Sahin D. G., Dogu M. H., Ayyildiz O., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

26. FEBRİL NÖTROPENİ ATAKLARINDA ANTİBİYOTİK MODİFİKASYON NEDENLERİ TURGUT ÖZAL TIP MERKEZİ HEMATOLOJİ KLİNİĞİ DENEYİMİ

KÖROĞLU M., KUKU İ., ERKURT M. A., KAYA E., NİZAM İ., BERBER İ., et al.

39. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 23 - 26 Ekim 2013, ss.89-90

27. PRIMARY BREAST LYMPHOMA IN A MALE PATIENT

BERBER İ., ERKURT M. A., yiğit a., KAYA E., KUKU İ., KÖROĞLU M., et al.

IV. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, Antalya, Türkiye, 9 - 13 Ekim 2013, cilt.3, ss.129

28. MULTIPLE MYELOMA PRESENTING WITH BLEEDING DIATHESIS A CASE REPORT

NİZAM İ., ERKURT M. A., KAYA E., BERBER İ., KÖROĞLU M., BENTLİ R., et al.

4. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 9 - 13 Ekim 2013

29. CHRONIC MYELOİD LEUKEMIA PRESENTING A MAN WİTH A AT CHONDROPLASIA A RARE CASEINTRODUCTlON

NİZAM İ., ERKURT M. A., KAYA E., KÖROĞLU M., BERBER İ., BENTLİ R., et al.

4. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 9 - 13 Ekim 2013

30. AKUT MYELOİD LÖSEMİDE CİLT MUAYENESİ VE ÖNEMİ

BERBER İ., ERKURT M. A., KAYA E., NİZAM İ., KUKU İ., KÖROĞLU M., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013

31. TURGUT ÖZAL TIP MERKEZİNDE BÖLÜMLERE GÖRE KAN VE KAN ÜRÜNÜ ÇIKIŞI

KÖROĞLU M., BERKTAŞ H. B., ERKURT M. A., KUKU İ., KAYA E., NİZAM İ., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013, ss.162-163

32. Metotreksata Bağlı Toksik Epidermal Nekrolizis

YILMAZ S., BERBER İ., ERKURT M. A., KAYA E., KÖROĞLU M., NİZAM İ., et al.

8.ULUSAL AFEREZ KONGRESİ, Türkiye, 5 - 08 Eylül 2013

33. SUCCESSFUL TREATMENT OF HELLP SYNDROME BY PLASMAPHERESIS

ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KÖROĞLU M., NİZAM İ., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013

34. ÖLÜMCÜL SEYREDEBİLEN BİR HASTALIK SOĞUK HEMAGLÜTİNİN HASTALIĞI

YAĞAR Y., KÖROĞLU M., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013, ss.164

35. İNÖNÜ ÜNİVERSİTESİ TURGUT ÖZAL TIP MERKEZİ AFEREZ ÜNİTESİNDE TOPLANAN TROMBOSİTLERİN HAZIRLANIŞ ŞEKİLLERİNE GÖRE SAYILARI

KAYA E., ERKURT M. A., BERBER İ., KÖROĞLU M., NİZAM İ., ULU E., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013

36. Experience Of BK Virus In Allogenic And Otolog Bone Marrow Transplantation

ERKURT M. A., BERBER İ., KAYA E., KÖROĞLU M., NİZAM İ., KUKU İ., et al.

Ulusal Aferez Kongresi, Türkiye, 5 - 08 Eylül 2013

37. KEMİK İLİĞİ İNCELEMESİ SONRASINDA NADİR BİR KOMPLİKASYON A V FİSTÜL

BERBER İ., ERKURT M. A., BAZNA S., KAYA E., NİZAM İ., KÖROĞLU M., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013, ss.149-150

38. AKUT MYELOİD LÖSEMİLİ ÜÇ OLGUDA GELİŞEN ÖNEMLİ BİR PROBLEM TROMBOSİT ALLOİMMÜNİZASYONU

KÖROĞLU M., ERKURT M. A., KAYA E., BERBER İ., KUKU İ.

38. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2012, ss.90-91

39. MULTİPLE MYELOMDA OTOLOG KEMİK İLİĞİ NAKLİ DENEYİMİMİZ

BERBER İ., ERKURT M. A., KAYA E., KUKU İ., KÖROĞLU M.

38. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2012, ss.229-230

40. İMMÜN TROMBOSİTOPENİLİ HASTALARIMIZIN DEMOGRAFİK VERİLERİ VE KLİNİK ÖZELLİKLERİ TEDAVİ SONUÇLARI

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., KÖROĞLU M.

38. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 03 Kasım 2012

41. AKUT MYELOİD LÖSEMİ HASTALARINDA HİPERLÖKOSİTOZ

KÖROĞLU M., BERBER İ., ERKURT M. A., KAYA E., KUKU İ.

38. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2012, ss.99

42. İMMÜN TROMBOSİTOPENİN BİRİNCİ BASAMAK TEDAVİSİNDE DEKSAMETAZON DENEYİMİMİZ

ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M., ÖZDEMİR Z.

38. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 03 Kasım 2012

43. AKUT MYELOİD LÖSEMİ M3 TİPİ OLGULARIMIZ

KÖROĞLU M., ERKURT M. A., KAYA E., BERBER İ., KUKU İ.

38. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2012, ss.91

44. HEMATOLOJİ KONSÜLTASYONU İSTENEN HASTALARIN BÖLÜMLERE VE İSTEM NEDENLERİNE GÖRE DAĞILIMI

KÖROĞLU M., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

38. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 04 Kasım 2012

45. ERİŞKİNDE LANGERHANS HÜCRELİ HİSTİYOSİTOZİS OLGU SUNUMU

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., KÖROĞLU M., ÖZDEMİR Z.

38. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 03 Kasım 2012

46. ALLOJENİK KEMİK İLİĞİ NAKLİ SONRASI HEMORAJİK SİSTİT ETKENİ BK VİRÜS

ERKURT M. A., BERBER İ., KAYA E., OĞUZ F., KUKU İ., KÖROĞLU M.

38. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2012, ss.132-133

47. HAND FOOT SYNDROME CASE IN INONU UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF HAEMATOLOGY

KAYA E., KARINCAOĞLU Y., ERKURT M. A., KUKU İ., BERBER İ., KÖROĞLU M., et al.

III. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, Antalya, Türkiye, 17 - 21 Ekim 2012, cilt.2, ss.300

48. HAND FOOT SYNDROME CASE İN İNONİJUNIVERSITY FACULTY OF MEDİCİNEDEPARTMENT OF HEMATOLOGY

KAYA E., KARINCAOĞLU Y., ERKURT M. A., KUKU İ., BERBER İ., KÖROĞLU M., et al.

3. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 17 - 21 Ekim 2012

49. Thrombotic Thrombocytopenic Purpura presented with 43 times applied plasma exchange

ERKURT M. A., KAYA E., KUKU İ., KÖROĞLU M., BERBER İ.

14th INTERNATIONAL CONGRESS OF WORLD APHERESIS ASSOCIATION, Türkiye, 13 - 15 Eylül 2012, cilt.47, ss.48

50. STEM CELL TRANSPLANTATION EXPERIENCE OF TURGUT OZAL MEDICAL CENTER A SINGLE CENTER EXPERIENCE IN EASTERN ANATOLIA

ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KÖROĞLU M.

14th International Congress of the World Apheresis, İstanbul, Türkiye, 13 - 15 Eylül 2012, cilt.47, ss.27

51. KEMİK İLİĞİ NAKİL MERKEZİ KÜLTÜR SONUÇLARIMIZ TEK MERKEZ DENEYİMİ

KÖROĞLU M., BERBER İ., KAYA E., ERKURT M. A., KUKU İ.

7. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 8 - 10 Mart 2012, ss.171, (Özet Bildiri)

Metrikler

Yayın

176

Yayın (WoS)

64

Yayın (Scopus)

59

Atıf (WoS)

274

H-İndeks (WoS)

4

Atıf (Scopus)

197

H-İndeks (Scopus)

9

Atıf (Scholar)

3

H-İndeks (Scholar)

1

Atıf (TrDizin)

4

H-İndeks (TrDizin)

1

Atıf (Sobiad)

2

H-İndeks (Sobiad)

1

Atıf (Diğer Toplam)

7

Proje

3

Açık Erişim

7

BM Sürdürülebilir Kalkınma Amaçları